Cathy Eng
凯西·英
MD, FACP, FASCO
David H. Johnson Chair in Surgical and Medical Oncology; Professor of Medicine外科与医学肿瘤学David H. Johnson讲席教授
👥Biography 个人简介
Dr. Cathy Eng is a nationally recognized GI oncologist at Vanderbilt known for her leadership in colorectal and anal cancer research. She has chaired landmark cooperative group trials and served on ASCO and NCCN guideline committees shaping the standard of care.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Anal Cancer Treatment Development
Led definitive trials establishing chemotherapy-immunotherapy regimens for advanced anal squamous cell carcinoma, changing first-line treatment paradigms.
Colorectal Cancer Systemic Therapy
Contributed to multiple phase III trials defining optimal sequencing of biologics and chemotherapy in metastatic colorectal cancer.
Representative Works 代表性著作
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer
Journal of Clinical Oncology (2020)
Established nivolumab as an effective option for MSI-H/dMMR colorectal cancer, supporting checkpoint inhibitor approvals.
Pembrolizumab with or without chemotherapy for first-line treatment of advanced anal cancer
Lancet Gastroenterology & Hepatology (2022)
Demonstrated benefit of adding pembrolizumab to standard chemotherapy in advanced anal cancer, a practice-changing result.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Zev Wainberg
UCLA Health / David Geffen School of Medicine
Daniel Coit
Memorial Sloan Kettering Cancer Center
Johanna Bendell
Sarah Cannon Research Institute
John Marshall
Georgetown University / Lombardi Comprehensive Cancer Center
关注 凯西·英 的研究动态
Follow Cathy Eng's research updates
留下邮箱，当我们发布与 Cathy Eng（Vanderbilt-Ingram Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment